This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Bayer expert disputes Tevra’s proffered relevant antitrust market, analysis at US jury trial

By Alex Wilts ( July 30, 2024, 01:53 GMT | Insight) -- Tevra Brands’ analysis of the market for pet products used to treat fleas and ticks is “wrong,” a Bayer Healthcare expert told a jury today at a US trial over whether exclusivity agreements Bayer offered to pet-specialty retailers and distributors were aimed at helping the company illegally maintain its monopoly for the sale of certain remedies.Tevra Brands’ analysis of the market for pet products used to treat fleas and ticks is “wrong,” a Bayer Healthcare expert told a jury today at a US trial over whether Bayer’s exclusivity agreements with pet-specialty retailers and distributors helped the company illegally maintain its monopoly for the sale of certain remedies....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections